Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2014 09:30 ET | Source: Department of Canadian Heritage

A Taste of the Far West in Saint-Tite: Experience Country at Its Best

SAINT-TITE, QUEBEC--(Marketwired - Sept. 7, 2014) - Canadian Heritage and Canada Economic Development for Quebec Regions (CED) The Honourable Shelly Glover, Minister of Canadian...
September 07, 2014 09:00 ET | Source: The MobilityWorks Foundation Cars for Troops

The MobilityWorks Foundation Cars for Troops Program Raises $250,000 for Veterans With Disabilities at Mecum Dallas Auction

AKRON, OH--(Marketwired - Sep 7, 2014) - MobilityWorks, the largest provider of consumer and commercial wheelchair-accessible vehicles in the United States, is pleased to announce the sale of a...
September 07, 2014 07:00 ET | Source: Novartis Pharma AG

Novartis data at ERS 2014 show once-daily Ultibro® Breezhaler® is superior in reducing COPD flare ups compared to Seretide®*

Once-daily Ultibro® Breezhaler® reduced exacerbations (flare ups) by 31% compared to twice-daily Seretide® Accuhaler®* in moderate-to-severe COPD patients[1] LANTERN study further confirmed...
September 07, 2014 04:30 ET | Source: Top Image Systems Ltd.

Top Image Systems Ltd. Announces Participation at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014

NEW YORK and TEL AVIV, Israel, Sept. 7, 2014 (GLOBE NEWSWIRE) -- Top Image Systems, Ltd. (Nasdaq:TISA), a leading ECM (Enterprise Content Management) and BPM (Business Process Management) solution and...
September 06, 2014 12:01 ET | Source: Melinta Therapeutics

Melinta Therapeutics and Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity against Complicated Urinary Tract Infection Pathogens

NEW HAVEN, Conn, Sept. 6, 2014 (GLOBE NEWSWIRE) -- Melinta Therapeutics and Hartford Hospital today announced in vitro results from an investigator-sponsored study that highlight delafloxacin's...
September 06, 2014 12:01 ET | Source: Melinta Therapeutics

Melinta Therapeutics Reports on PK Profile of a Single Oral Dose of Delafloxacin in Support of U.S. Phase 3 Gonorrhea Program

NEW HAVEN, Conn, Sept. 6, 2014 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced results of a Phase 1 study of delafloxacin, an investigational fluoroquinolone, in healthy adults that...
September 06, 2014 11:00 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting

RESEARCH TRIANGLE PARK, N.C., Sept. 6, 2014 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced trial results related to RAPIVAB™ (peramivir injection), a...
September 06, 2014 10:49 ET | Source: Novavax, Inc.

Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC

GAITHERSBURG, Md., Sept. 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
September 06, 2014 09:23 ET | Source: Equifax Inc.

Equifax to Present at Barclays Conference

ATLANTA, Sept. 6, 2014 (GLOBE NEWSWIRE) -- Equifax Inc. (NYSE:EFX) announced that Jeff Dodge, Senior Vice President of Investor Relations will discuss the company's year-to-date 2014 performance and...
September 06, 2014 08:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea's partner Astellas receives notification from U.S. FDA of acceptance of filing of isavuconazole NDA for the treatment of invasive aspergillosis and invasive mucormycosis

Basel, Switzerland, September 06, 2014 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reports today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application for...

1 ...229252 229253 229254 ...326051